Navigation Links
Bionovo Announces Second Quarter 2009 Highlights and Financial Results
Date:8/10/2009

EMERYVILLE, Calif., Aug. 10 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI) today announced second quarter highlights and financial results for the three months ended June 30, 2009.

Company Highlights

    -- Further results from the phase 1B clinical trial of Bezielle (BZL101)
       in 27 patients with metastatic breast cancer showed Bezielle to be
       safe and well-tolerated with encouraging evidence of clinical activity
       in a heavily pretreated patient population - most importantly
       including:

       -- 31% had stable disease for more than 90 days;
       -- 13% had stable disease for more than 180 days;
       -- three patients had objective tumor regression;
       -- one patient had objective tumor regression while on Bezielle
          therapy for 449 days and continues to be stable off of study
          medication for over 600 days;
       -- a second patient continues to be stable for 832 days and has not
          started any new anticancer treatment;
       -- a third patient was stable without any new anticancer therapy for
          591 days;
       -- there were no deaths or serious adverse events that were attributed
          to Bezielle (BZL101); and
       -- the most common side effects associated with Bezielle (BZL101) were
          minor and gastrointestinal in nature.


       These results provide further evidence that Bezielle (BZL101) may
       provide an important option for women suffering from advanced breast
       cancer, an extremely difficult to treat subset of the breast cancer
       population.

    -- On the SERM platform, a peer-reviewed study published in the journal
       "Public Library of Science One" found that when comparing the gene
       expression induced by ERb compounds to that induced by est
'/>"/>
SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
2. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
5. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
7. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
8. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
9. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
11. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... BURLINGTON, Mass. , Aug. 20, 2014 ... Japanese electrophysiology (EP) mapping and ablation device ... increasingly use ablation to treat atrial fibrillation ... a primary treatment option for AF will ... for this application, such as advanced loop ...
(Date:8/20/2014)... LAKE CITY , Aug. 20, 2014 ... revolutionary mobile diagnostic platform during a special event at ... Utah , on September 5, 2014. The event, ... LiveStreamed on the ApolloDx website, www.apollodx.com .    ... transform diagnostic testing," said Jared Bauer , Co-Founder ...
(Date:8/20/2014)... Aug. 20, 2014 Reportlinker.com announces that ... its catalogue: The Market for Medical ... The European, Middle Eastern and African markets ... As part of its coverage, this study: The ... the EMEA medical device markets and estimates markets ...
Breaking Medicine Technology:Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 2Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 3The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5
... (Nasdaq: PRGO;TASE) today announced that Perrigo CFO Judy ... Global Healthcare Conference on Wednesday, February 15th, at ... New York.   Perrigo Company is ... and distributes OTC and generic prescription (Rx) pharmaceuticals, ...
... 2012 Boston Scientific Corporation (NYSE: BSX ) ... Healthcare Conference on February 15 in New York. ... Capello, Executive Vice President and Chief Financial Officer, will participate ... beginning at approximately 11:00 a.m. ET. A live ...
Cached Medicine Technology:Perrigo Company to Present at the Leerink Swann 2012 Global Healthcare Conference 2Boston Scientific to Participate in Leerink Swann 2012 Global Healthcare Conference 2
(Date:8/20/2014)... The report “Automotive Airbag and Seat ... Analysis: by Geography - Trends and Forecasts 2014 ... automotive airbag and seatbelt market in terms of ... opportunities in the coming years as well as ... growth indicators, challenges, legislation trends, market dynamics, competitive ...
(Date:8/20/2014)... Pass, OR (PRWEB) August 20, 2014 ... parents are urged to become educated about eye health ... eye examined. One frequently overlooked eye condition that must ... the Sharon Kleyne Hour Power of Water radio show, ... young children increasing exponentially, childhood dry eye is becoming ...
(Date:8/20/2014)... August 20, 2014 B. E. Smith, ... healthcare providers, has been retained to lead a national ... Health Care System in Hermiston, Ore. The top ... E. Smith has recently placed more than 900 healthcare ... System is a progressive, not-for-profit healthcare organization serving a ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Hope For ... Give Hope® Celebration to be hosted in Washington, DC ... Navy Club. This signature event honors the courage of ... of the fallen. Proceeds from the Got Heart, Give ... national nonprofit dedicated to restoring a sense of self, ...
(Date:8/20/2014)... Inc. Magazine recently named Etransmedia ... annual Inc. 500|5000, an exclusive ranking of the ... most comprehensive look at the most important segment ... Yelp, Pandora, Timberland, Dell, Domino’s Pizza, LinkedIn, Zillow ... as members of the Inc. 500|5000. , “We ...
Breaking Medicine News(10 mins):Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 4Health News:August is Children’s Eye Health Month, Exams Must Check for Pediatric Dry Eye 2Health News:August is Children’s Eye Health Month, Exams Must Check for Pediatric Dry Eye 3Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 2Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 3Health News:Hope For The Warriors Announces Got Heart, Give Hope Celebration in Washington, DC 2Health News:Etransmedia Makes Exclusive List for the Eighth Consecutive Year in Inc. Magazine 2Health News:Etransmedia Makes Exclusive List for the Eighth Consecutive Year in Inc. Magazine 3
... U.S. Food and Drug Administration (FDA) today cleared for U.S. ... save the arms and legs of soldiers critically injured// in ... emergency situations. ,FDA reviewed the Temporary Limb ... less than one week because of the critical need for ...
... New research suggests that strep infections in children may ... psychiatric disorders. ,In an eight-month study of ... of Florida researchers found that shortly after the number ... a corresponding rise in involuntary movements and disruptive behaviors ...
... of nine and 12 are most likely to gain weight, a ... more than 2,300 girls aged nine and 10 and followed them ... weight, blood pressure and cholesterol every year through age 18, then ... 23. Roughly half of the girls were white and half were ...
... doctors of Indian origin in Britain - many of them ... - after they lost a case Friday against changes in ... in the country's National Health Service (NHS). ,Many ... of returning home, while others waiting to find employment find ...
... link between zinc supplementation and reduced atherosclerosis in rabbit ... to their hypothesis that the effect may be due ... ,Researchers from the National University of Singapore reported ... year that supplementation of a high cholesterol diet with ...
... In the recent years, scientists discovered a family of ... organisms// as diverse as yeast, worms, and flies. ... Wistar Institute points to another strategy for activating sirtuins ... able to control age-associated metabolic disorders, including obesity and ...
Cached Medicine News:Health News:FDA Clears Critical Limb-Saving Vascular Device 2Health News:Strep, Psychiatric Symptoms Possibly Linked in Some Children 2Health News:Strep, Psychiatric Symptoms Possibly Linked in Some Children 3Health News:Adolescent Girls More Likely to Gain Weight: Study 2Health News:Indian Doctors in Britain Lose Legal Battle 2Health News:Indian Doctors in Britain Lose Legal Battle 3Health News:Indian Doctors in Britain Lose Legal Battle 4Health News:More Support for Zinc-antiatherogenic Link 2Health News:More Support for Zinc-antiatherogenic Link 3Health News:Anti-Aging Powers of Enzyme Sirtuins 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: